Lysophosphatidylinositol

Source: Wikipedia, the free encyclopedia.
Lysophosphatidylinositol
Names
IUPAC name
[(2R)-2-hydroxy-3-[hydroxy-[(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]-oxyphosphoryl]oxypropyl] hexadecanoate
Identifiers
3D model (
JSmol
)
  • CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC1[C@@H]([C@H](C([C@H]([C@H]1O)O)O)O)O)O
Properties
C25H49O12P
Molar mass 572.629 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Lysophosphatidylinositol (LPI, lysoPI), or L-α-lysophosphatidylinositol, is an

endocannabinoid neurotransmitter.[1] LPI, along with its 2-arachidonoyl- derivative, 2-arachidonoyl lysophosphatidylinositol (2-ALPI), have been proposed as the endogenous ligands of GPR55.[2][3][4][5]

See also

References

  1. PMID 29769317
    .
  2. PMID 17765871
    .
  3. S2CID 27142069
    .
  4. PMID 22285325
    .
  5. PMID 18845565
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Lysophosphatidylinositol&oldid=1215942332"